LATEST NEWS
COVID-19 VACCINE PHASE 1 CLINICAL TRIAL DATA WITH BIONTECH
Click to see a news release regarding our partner, BioNTech, and their clinical trial data for a COVID-19 vaccine. Our proprietary lipid nanoparticles are an important aspect of BioNTech’s mRNA vaccine. Link
UNIVERSAL INFLUENZA VIRUS VACCINE
Collaboration with Dr. Nachbagauer in the development of a universal influenza virus vaccine (Mol Ther 2020). Link
NATURE - APRIL 2020
Collaboration with Dr. Kurtis in the development of a vaccine based on PfGARP that partially protects subjects against malaria challenge (Nature 2020). Link